Skip to main content
. 2024 Feb 14;39(8):e76. doi: 10.3346/jkms.2024.39.e76

Table 1. Characteristics of the individual case safety reports following vaccination among adolescents (12–17 years) retrieved from World Health Organization VigiBase.

Characteristics COVID-19 vaccination All other vaccinationa
No. of reports 80,018 19,717
Sex
Male 37,706 (47.1) 8,606 (43.7)
Female 42,312 (52.9) 11,111 (56.3)
Region
African 2,319 (2.9) 1,551 (7.8)
Americas 45,023 (56.3) 11,330 (57.5)
South-East Asia 706 (0.9) 40 (0.2)
Europe 19,544 (24.4) 4,706 (23.9)
Eastern Mediterranean 1,398 (1.8) 27 (0.1)
Western Pacific 11,028 (13.8) 2,063 (10.5)
Type of report
Spontaneous 77,482 (96.8) 19,447 (98.6)
Report from study 1,202 (1.5) 184 (0.9)
Others 1,334 (1.7) 85 (0.5)
Notifier
Physician 9,571 (11.9) 2,459 (12.5)
Pharmacist 3,248 (4.1) 569 (2.9)
Other health professional 10,044 (12.6) 3,109 (15.8)
Others 57,155 (71.4) 13,580 (68.8)
Type of vaccine
mRNA 76,200 (95.2) -
Viral vector 2,315 (2.9) -
Inactivated 883 (1.1) -
Subunit 250 (0.3) -
Unknown 370 (0.5) 0 (0)
Viral - 11,541 (58.5)
Bacterial - 7,613 (38.6)
Vira-bacterial combined - 554 (2.8)
Other - 9 (0.1)

Values are presented as number (%).

COVID-19 = coronavirus infectious disease 2019.

aAll other vaccines include papillomavirus vaccine (5,825), meningococcal vaccine (5,321), influenza vaccine (2,401), pertussis vaccine (1,627), hepatitis vaccine (1,052), measles vaccine (1,020), bacterial and viral vaccines, combined (554), varicella zoster vaccine (451), tetanus vaccine (381), poliomyelitis vaccine (381), yellow fever vaccine (185), pneumococcal vaccine (175), encephalitis vaccines (91), other viral vaccines (79), rabies vaccine (49), cholera vaccine (36), haemophilus influenza B vaccine (36), typhoid vaccine (24), tuberculosis vaccine (10), rubella vaccine (6), diphtheria vaccine (4), anthrax vaccine (2), rotavirus diarrhea vaccine (1), and other vaccines (6).